Aiai Gao

#28 Fuxing Road
Beijing, 100853, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Epigenetic silencing L3MBTL4 sensitizes esophageal cancer to DNA-PKcs inhibitor.

Epigenetic silencing L3MBTL4 sensitizes esophageal cancer to DNA-PKcs inhibitor.

Journal: Cancer biology & therapy

Published: March 25, 2026

L3MBTL4 methylation is a sensitive marker of DNA-PK inhibitor in pancreatic cancer.

L3MBTL4 methylation is a sensitive marker of DNA-PK inhibitor in pancreatic cancer.

Journal: Exploration of targeted anti-tumor therapy

Published: December 24, 2025

Lnc5q21.2, a novel long intergenic RNA, sensitizes colorectal cancer cells to ATR inhibitor by activating Wnt pathway.

Lnc5q21.2, a novel long intergenic RNA, sensitizes colorectal cancer cells to ATR inhibitor by activating Wnt pathway.

Journal: Journal of translational internal medicine

Published: October 31, 2025

Defect of MLH1 expression sensitized esophageal squamous cell carcinoma cells to Polθ inhibitor.

Defect of MLH1 expression sensitized esophageal squamous cell carcinoma cells to Polθ inhibitor.

Journal: Epigenomics

Published: October 30, 2025

A novel lncRNA, Lnc21q22.11, suppresses gastric cancer growth by inhibiting MEK/ERK pathway.

A novel lncRNA, Lnc21q22.11, suppresses gastric cancer growth by inhibiting MEK/ERK pathway.

Journal: Epigenetics

Published: June 02, 2025

The atypical Dof transcriptional factor OsDes1 contributes to stay-green, grain yield, and disease resistance in rice.

The atypical Dof transcriptional factor OsDes1 contributes to stay-green, grain yield, and disease resistance in rice.

Journal: Science advances

Published: August 23, 2024

Methylation of FAM110C is a synthetic lethal marker for ATR/CHK1 inhibitors in pancreatic cancer.

Methylation of FAM110C is a synthetic lethal marker for ATR/CHK1 inhibitors in pancreatic cancer.

Journal: Journal of translational internal medicine

Published: July 31, 2024

Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling.

Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling.

Journal: Epigenomics

Published: July 18, 2024

Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling.

Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling.

Journal: Cancer biology & therapy

Published: January 16, 2024

RASSF1A promotes ATM signaling and RASSF1A methylation is a synthetic lethal marker for ATR inhibitors.

RASSF1A promotes ATM signaling and RASSF1A methylation is a synthetic lethal marker for ATR inhibitors.

Journal: Epigenomics

Published: December 14, 2023

Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer.

Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer.

Journal: Frontiers of medicine

Published: July 21, 2023

Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer.

Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer.

Journal: Clinical and translational gastroenterology

Published: July 21, 2023

Showing 1-12 of 16

Last Updated: 09/26/2026